Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Themis Medicare Limited (THEMISMED) Stock Price & Analysis

1 Followers

THEMISMED Stock Chart & Stats

₹102.12-₹1.36(-1.31%)
At close: 3:30 PM GMT+5:30
₹100₹125Aug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 99.01 - INR 103.59
52-Week Range
INR 65.00 - INR 141.05
Previous Close
INR 103.48
Volume
N/A
Average Volume (3M)
3,233
Market Cap
INR 9.53B
Enterprise Value
INR 6.98B
Total Cash (Recent Filing)
INR 91.50M
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
23.5
Beta
1.28
Next Earnings
Feb 14, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Sep 23, 2026
Dividend Yield
0.49%

Bulls Say, Bears Say

Bulls Say

Revenue Rebound

The strong latest-year revenue rebound indicates renewed demand for the company’s pharmaceutical formulations and APIs. If sustained, higher sales can improve operating leverage, support reinvestment across manufacturing and distribution, and strengthen the company’s ability to compete over the next several quarters.

Manageable Leverage

Moderate leverage provides a degree of balance-sheet resilience and reduces the burden of debt service relative to a highly leveraged capital structure. This should preserve financial flexibility to fund operations and pursue growth, provided profitability and cash generation recover.

Substantial Equity Base

A sizable equity base gives Themis Medicare a stronger capital cushion against operating volatility and supports continued investment in its pharmaceutical manufacturing and marketing activities. This financial foundation can help the company absorb weaker periods while rebuilding returns.

Bears Say

Severe Margin Erosion

The sharp deterioration in gross and operating margins shows that revenue growth is not currently translating into healthy earnings. Persistent margin pressure would weaken reinvestment capacity, reduce resilience to business volatility, and limit the long-term value of additional sales.

Negative Cash Generation

Negative operating and free cash flow indicate weak conversion of reported business activity into cash. If this persists, Themis Medicare may have less internally generated funding for capital expenditure and working capital, increasing reliance on external financing during the next several quarters.

Collapsed Shareholder Returns

The collapse in return on equity indicates that the company’s capital base is currently producing very little profit for shareholders. Unless profitability improves, weak returns can constrain retained earnings growth and signal inefficient use of the resources supporting the business.

Themis Medicare Limited News

THEMISMED FAQ

What was Themis Medicare Limited’s price range in the past 12 months?
Themis Medicare Limited lowest stock price was ₹65.00 and its highest was ₹141.05 in the past 12 months.
What is Themis Medicare Limited’s market cap?
Themis Medicare Limited’s market cap is ₹9.53B.
When is Themis Medicare Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Themis Medicare Limited’s earnings last quarter?
Themis Medicare Limited released its earnings results on Aug 13, 2026. The company reported ₹2.672 earnings per share for the quarter.
Is Themis Medicare Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Themis Medicare Limited pay dividends?
Themis Medicare Limited pays an annual dividend of ₹0.5 which represents an annual dividend yield of 0.49%. See more information on Themis Medicare Limited dividends here
What is Themis Medicare Limited’s EPS estimate?
Themis Medicare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Themis Medicare Limited have?
Themis Medicare Limited has 92,100,120 shares outstanding.
What happened to Themis Medicare Limited’s price movement after its last earnings report?
Themis Medicare Limited reported an EPS of ₹2.672 in its last earnings report. Following the earnings report the stock price went up 1.216%.
Which hedge fund is a major shareholder of Themis Medicare Limited?
Currently, no hedge funds are holding shares in IN:THEMISMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology